Type 1 diabetes and the microbiota: MAIT cells as biomarkers and new therapeutic targets

Scientists have discovered that the onset of type 1 diabetes is preceded by modification of MAIT lymphocytes. These cells--associated with mucosae and able to recognize elements of the microbiota--could therefore serve as new biomarkers for early detection and prevention of the illness.